Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» In cost debate, Amgen stands by Repatha's value
In cost debate, Amgen stands by Repatha's value
In cost debate, Amgen stands by Repatha's value
Submitted by
admin
on August 23, 2017 - 11:36am
Source:
BioPharma Dive
News Tags:
Amgen
Repatha
drug pricing
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Headline:
In cost debate, Amgen stands by Repatha's value
Do Not Allow Advertisers to Use My Personal information
